Galectin Therapeutics Inc (GALT) stock
GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.98+0.07 (+2.41%)
Close on Nov 18, 2026Market cap $300.53MP/E –Yield –
Galectin Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Galectin Therapeutics's price to book ratio was 103.0× on Apr 29, 2022, against 11.2× a year earlier. Over the last 5 years it ranged from 2.5× to 258.8×, with a median of 13.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 103.0× | +86.7 |
| 2021 | Dec 31, 2021 | 16.3× | +12.0 |
| 2020 | Dec 31, 2020 | 4.3× | +0.9 |
| 2019 | Dec 31, 2019 | 3.4× | −16.1 |
| 2018 | Dec 31, 2018 | 19.5× | −106.2 |
| 2017 | Dec 29, 2017 | 125.7× | +122.9 |
| 2016 | Dec 30, 2016 | 2.8× | −0.3 |
| 2015 | Dec 31, 2015 | 3.1× | −0.2 |
| 2014 | Dec 31, 2014 | 3.3× | −106.4 |
| 2013 | Dec 31, 2013 | 109.7× | +99.0 |
| 2012 | Dec 31, 2012 | 10.7× | −79.0 |
| 2011 | Dec 30, 2011 | 89.7× | – |
See a number that looks wrong?